methylprednisolone has been researched along with Enteropathy, Exudative in 12 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 3 (25.00) | 18.7374 |
| 1990's | 3 (25.00) | 18.2507 |
| 2000's | 6 (50.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Hoshino, M; Kamimura, T; Minota, S; Morino, N; Nagashima, T; Okazaki, H; Shimoji, S | 1 |
| Hashimura, Y; Hayakawa, A; Iijima, K; Kanegane, H; Matsuo, M; Miyawaki, T; Nakanishi, K; Nozu, K; Takemoto, M; Yoshikawa, N | 1 |
| Chen, DY; Hsieh, TY; Lan, JL | 1 |
| Gottlieb, JL; Multari, A; Thomassen, TS; Venkatramani, J | 1 |
| Ikeda, T; Imai, K; Motoya, S; Sone, A; Sugaya, T; Suzuki, J; Taga, M; Takahashi, H; Tsukuda, H; Yasui, H | 1 |
| Bélaïche, J; Carlet, J; Cattan, D; Kalifat, R; Rapin, M; Vesin, P | 1 |
| Haruma, K; Inoue, M; Kajiyama, G; Kumai, H; Matsumura, M; Mieno, H; Sumii, M; Tamaki, K; Tanaka, N; Yoshihara, M | 1 |
| Erkan, D; Levine, DM; Lockshin, MD; Parker, TS; Yazici, Y | 1 |
| Demura, H; Furuya, T; Kashiwazaki, S; Onoda, N; Sato, K; Suzuki, T; Tamura, K | 1 |
| Grange, JD; Marteau, P; Meulders, Q; Michel, C; Mignon, F; Mougenot, B; Ronco, P | 1 |
| Dehos, H; Ewe, K; Karbach, U | 1 |
| Linscheer, WG; Pachas, WN; Pinals, RS | 1 |
3 review(s) available for methylprednisolone and Enteropathy, Exudative
| Article | Year |
|---|---|
[Case of systemic lupus erythematosus with protein-losing gastroenteropathy].
Topics: Adult; Anti-Inflammatory Agents; Female; Humans; Lupus Erythematosus, Systemic; Methylprednisolone; Protein-Losing Enteropathies; Serum Albumin | 1996 |
Protein-losing enteropathy in systemic lupus erythematosus: report of a severe, persistent case and review of pathophysiology.
Topics: Adult; Cyclophosphamide; Female; Humans; Interleukin-6; Lupus Erythematosus, Systemic; Methylprednisolone; Protein-Losing Enteropathies; Tumor Necrosis Factor-alpha | 2002 |
Association of chronic interstitial cystitis, protein-losing enteropathy and paralytic ileus with seronegative systemic lupus erythematosus: case report and review of the literature.
Topics: Adult; Cyclophosphamide; Cystitis; Female; Humans; Intestinal Pseudo-Obstruction; Lupus Erythematosus, Systemic; Methylprednisolone; Protein-Losing Enteropathies | 1992 |
9 other study(ies) available for methylprednisolone and Enteropathy, Exudative
| Article | Year |
|---|---|
Protein-losing gastroenteropathy associated with primary Sjögren's syndrome: a characteristic oriental variant.
Topics: Adult; Albumins; alpha 1-Antitrypsin; Asian People; Erythema; Gastrointestinal Tract; Humans; Japan; Male; Metabolic Clearance Rate; Methylprednisolone; Protein-Losing Enteropathies; Racial Groups; Radionuclide Imaging; Sjogren's Syndrome; Treatment Outcome | 2009 |
Minimal change nephrotic syndrome associated with immune dysregulation, polyendocrinopathy, enteropathy, X-linked syndrome.
Topics: CD4-Positive T-Lymphocytes; Child, Preschool; Cyclosporine; DNA; Forkhead Transcription Factors; Gene Deletion; Genetic Diseases, X-Linked; Humans; Immunosuppressive Agents; Interleukin-2 Receptor alpha Subunit; Male; Methylprednisolone; Nephrotic Syndrome; Polyendocrinopathies, Autoimmune; Protein-Losing Enteropathies; Secondary Prevention; Sequence Analysis, DNA; T-Lymphocytes, Regulatory; Treatment Outcome | 2009 |
Primary Sjögren's syndrome with protein-losing gastroenteropathy: report of two cases.
Topics: Adult; Female; Humans; Methylprednisolone; Middle Aged; Protein-Losing Enteropathies; Sjogren's Syndrome; Technetium Tc 99m Aggregated Albumin | 2002 |
Bilateral serous retinal detachment due to protein-losing enteropathy.
Topics: Female; Fluorescein Angiography; Glucocorticoids; Humans; Methylprednisolone; Middle Aged; Protein-Losing Enteropathies; Retinal Detachment; Ultrasonography | 2004 |
[Case of protein-losing gastroenteropathy associated with scleroderma in which central serous chorioretinopathy developed].
Topics: Adult; Chorioretinitis; Female; Humans; Methylprednisolone; Prednisolone; Protein-Losing Enteropathies; Pulse Therapy, Drug; Scleroderma, Systemic; Treatment Outcome | 2001 |
[Protein-losing enteropathy and inflammatory process. Resolution after intravenous methylprednisolone "pulses" (author's transl)].
Topics: Adult; Drug Administration Schedule; Female; Humans; Inflammation; Injections, Intravenous; Intestinal Diseases; Methylprednisolone; Protein-Losing Enteropathies | 1982 |
Mixed connective tissue disease associated with protein losing enteropathy: successful treatment with intravenous cyclophosphamide therapy.
Topics: Antigens, Tumor-Associated, Carbohydrate; Biomarkers; Cyclophosphamide; Drug Administration Schedule; Female; Humans; Injections, Intravenous; Methylprednisolone; Middle Aged; Mixed Connective Tissue Disease; Prednisolone; Protein-Losing Enteropathies | 1992 |
Antiinflammatory treatment and intestinal alpha 1-antitrypsin clearance in active Crohn's disease.
Topics: Adolescent; Adult; alpha 1-Antitrypsin; Anti-Inflammatory Agents; Crohn Disease; Feces; Female; Humans; Intestinal Mucosa; Male; Methylprednisolone; Middle Aged; Protein-Losing Enteropathies; Serum Albumin; Sulfasalazine | 1985 |
Protein-losing enteropathy in systemic lupus erythematosus.
Topics: Female; Humans; Intestinal Mucosa; Intestine, Small; Jejunum; Lupus Erythematosus, Systemic; Methylprednisolone; Middle Aged; Neutrophils; Prednisone; Protein-Losing Enteropathies; Radiography; Synovial Fluid | 1971 |